HASHEM EL-SERAG to Longitudinal Studies
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Longitudinal Studies.
Connection Strength
0.228
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
Score: 0.076
-
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis. Hepatol Commun. 2026 Mar 01; 10(3).
Score: 0.044
-
Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Aliment Pharmacol Ther. 2005 Feb 01; 21(3):235-42.
Score: 0.041
-
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. Hepatology. 2022 03; 75(3):541-549.
Score: 0.033
-
Interferon: benefit beyond hepatitis therapy? Am J Gastroenterol. 2001 Dec; 96(12):3435-6.
Score: 0.033